Evidence map›Paper›PMID 41552933›Full record

ReviewJournal of biomaterials applications2026

Challenges and prospects of polymeric biomaterials in immune engineering: A review.

Boyka Andonova Lilova, Desislav Dinev, Probal Basu

Abstract readReview
In one paragraph

Review in Journal of biomaterials applications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Boyka Andonova LilovaDepartment of Agrobiotechnology, Agro-bioinstitute, Sofia, Bulgaria.
Desislav DinevFaculty of Medicine, Medical University of Sofia, Sofia, Bulgaria.
Probal BasuDepartment of Biomaterials, Institute of Clinical Dentistry, University of Oslo, Oslo, Norway (Old Affiliation).ORCID 0000-0001-5163-8002

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Immune engineering is a vast and rapidly developing field with a strong focus on polymeric materials. The importance of these biomaterials in immune engineering revolves around their ability to provide bioactive molecules to the target site, which influences the immune system. Their functional performance depends on various structural and functional properties of the biomaterial, which are also influenced by the host immune microenvironment. This work focuses on the current state of the art, the attributes of polymer-based biomaterials, and their limitations in immune engineering applications. This review not only elaborates on the advantages of polymeric biomaterials in immune engineering but also critically analyses the potential of these biomaterials in this field. The current work begins with the identification of key characteristics of polymer-based biomaterials for immune engineering, then explores different aspects of various polymeric materials and their importance in immune engineering applications. One of the key advantages of polymeric materials is that they can be efficiently designed to deliver bioactive molecules that significantly influence the host immune system. On the other hand, a notable limitation of these materials involves the development of adverse immune responses that can often occur due to the incompatibility of polymeric biomaterials with the host immune system. Finally, the review delves into the future perspectives and potential of these materials in immune engineering based personalized medicine and/or engineering living material (ELM) specific applications.

Indexed as

Biocompatible MaterialsImmune SystemPolymersTissue EngineeringAnimalsHumansBiocompatible MaterialsPolymersbiomaterialsimmune engineeringmacrophagepolymers

Identifiers

PMID41552933
PMCPMC13320338

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.